Clinical trial

Inhaled Versus Intravenous Milrinone for Patients Undergoing Mitral Valve Replacement Surgery

NCT05838846

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-04-01

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2023-04-01Date precision: day

Registry last updated2025-02-11

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Mitral Valve Replacementunresolved

Pulmonary Hypertensionunresolved

Inhaled Milrinoneunresolved

Intravenous Milrinoneunresolved

Interventions

Inhaled MilrinoneDRUG

IV MilrinoneDRUG

Sponsors & collaborators

Menoufia Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05838846 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.